The economic burden of rotavirus infection in South Korea from 2009 to 2012

被引:2
作者
Lee, Kyung Suk [1 ]
Lee, Ye-Rin [2 ]
Park, So-Youn [3 ]
Oh, In-Hwan [4 ]
机构
[1] CHA Univ, Dept Pediat, Sch Med, CHA Bundang Med Ctr, Seongnam, South Korea
[2] Kyung Hee Univ, Grad Sch, Dept Prevent Med, Seoul, South Korea
[3] Kyung Hee Univ, Sch Med, Dept Med Educ & Humanities, Seoul, South Korea
[4] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea
来源
PLOS ONE | 2018年 / 13卷 / 03期
关键词
VACCINE EFFECTIVENESS; CHILDREN; DIARRHEA; GASTROENTERITIS; EFFICACY; SAFETY;
D O I
10.1371/journal.pone.0194120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Rotavirus is a common cause of diarrhea worldwide, and vaccination prevents rotaviral gastroenteritis. Since the rotavirus vaccine was introduced in Korea in 2007, the prevalence of rotaviral gastroenteritis has decreased. However, little is known on the economic burden of rotavirus infection and its variations in Korea. Here, we estimated the economic costs of rotavirus infection from 2009 to 2012 using nationwide data from the National Health Insurance Service (NHIS) claims. Socioeconomic costs were subdivided into direct and indirect and measured with a prevalence-based approach. Costs were converted from Won to United States dollars (US$). The number of children <5 years old infected with rotavirus decreased from 21,437 to 10,295 during the study period, representing a decrease in prevalence from 947 to 443 per 100,000. The sum of direct and indirect costs also decreased, from $17.3 million to $9.6 million, and the days of admission decreased from 76,000 to 38,000. However, per capita expenditures slightly increased, from $809 to $934. Thus, the economic burden of rotavirus infection decreased after implementation of rotavirus vaccination. Including the vaccine as part of the national essential vaccination program could reduce the prevalence of and economic loss from rotavirus infection in Korea.
引用
收藏
页数:11
相关论文
共 38 条
[1]   Rotavirus Vaccine Effectiveness and Case-control Study on Risk Factors for Breakthrough Infections in Germany, 2010-2011 [J].
Adlhoch, Cornelia ;
Hoehne, Marina ;
Littmann, Martina ;
Marques, Andreas Mas ;
Lerche, Almuth ;
Dehnert, Manuel ;
Eckmanns, Tim ;
Wichmann, Ole ;
Koch, Judith .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) :E82-E89
[2]   Anticipating rotavirus vaccines - a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children &lt; 5 year of age in Libya, 2012-13 [J].
Alkoshi, Salem ;
Leshem, Eyal ;
Parashar, Umesh D. ;
Dahlui, Maznah .
BMC PUBLIC HEALTH, 2015, 15
[3]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533
[4]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P517
[5]  
[Anonymous], BIOMED RES INT
[6]  
[Anonymous], STUDY EFFECTIVENESS
[7]   Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines [J].
Chung, Ju-Young ;
Kim, Min-Sung ;
Jung, Tae Woong ;
Kim, Seong Joon ;
Kang, Jin-Han ;
Han, Seung Beom ;
Kim, Sang Yong ;
Rhim, Jung Woo ;
Kim, Hwang-Min ;
Park, Jae Hong ;
Jo, Dae Sun ;
Ma, Sang Hyuk ;
Jeong, Hye-Sook ;
Cheon, Doo-Sung ;
Kim, Jong-Hyun .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (10) :1471-1475
[8]  
Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes
[9]  
Jeong HJ, 2013, PUBLIC HLTH WKLY REP, V6, P925
[10]  
KEB Hana Bank, AV EXCH RAT 2012